Redcliffe Lifetech raises $61 mn for expansion; LeapFrog Investments leads

The funding to Redcliffe Lifetech would help the diagnostic platforms to expand access to affordable, high-quality diagnostic tests across India, especially in tier 2, 3, and 4 cities

Redcliffe Lifetech (Redcliffe), a leading diagnostics platform said it has raised $61 million led by LeapFrog Investments (LeapFrog), with participation from Healthquad, Schroders, LC Nueva, Growth Spark Ventures, and existing investors Chiratae Ventures and Alkemi Venture Partners. 

The investment will be used to expand Redcliffe’s geographic reach across India, with a focus on expanding its low-cost but high-quality direct-to-consumer diagnostics into tier 2, 3, and 4 cities. The funds would help it provide affordable, rapid, and convenient pathology services from glucose to genetics in millions of households. 

The funding will also be used to scale Redcliffe’s platform and increase its